John Stuelpnagel, D.V.M., MBACo-founder and former CEO of Illumina
Chairman of 10X Genomics, Ariosa & Inscripta
John R. Stuelpnagel is a member of the board of directors at Encoded Therapeutics and co-founder and chairman of Fabric Genomics, 10x Genomics and Inscripta.
Previously, Dr. Stuelpnagel co-founded Illumina (NASDAQ: ILMN) in 1998, serving as its first chief executive officer and later as its chief operating officer. He is a co-founder and was the executive chairman at Ariosa (sold to Roche) and was the chairman at Sequenta (sold to Adaptive Biotechnologies).
He holds a B.S. in Biochemistry and a doctorate in Veterinary Medicine from the University of California, Davis, and an MBA from the University of California, Los Angeles.